Pancreatic Cancer Awareness Month

Pancreatic-Cancer-Awareness-Month-November-1024x512.jpg

November is Pancreatic Cancer Awareness Month – Hirshberg Foundation for Pancreatic Cancer Research. Save the date – World Pancreatic Cancer Day – Nov. 21, 2019! November is an exciting time of year for communities around the globe raising awareness for pancreatic cancer, celebrating survivors and honoring loved ones.

No-Shave November

We are 15 days into No-Shave November, and we at Hope hospital and Ayushman Hospital, need your help in spreading awareness of men’s health issues, such as prostate cancer, testicular cancer, and men’s suicide and raising money to support cancer prevention and education! (Yes, this is a great cause, no we are not just lazy and forgetting to shave)

THE CONCEPT

The goal of No-Shave November is to grow awareness by embracing our hair, which many cancer patients lose, and letting it grow wild and free. Donate the money you typically spend on shaving and grooming to educate about cancer prevention, save lives, and aid those fighting the battle.

THE RULES

The rules of No-Shave November are simple: put down your razor for 30 days and donate your monthly hair-maintenance expenses to the cause. Strict dress-code at work? Don’t worry about it! We encourage participation of any kind; grooming and trimming are perfectly acceptable.

No shave November

Travel Abroad – Symptoms of Yellow Fever Vaccination

Yellow fever is a viral disease transmitted by mosquitoes in parts of Africa and South America. Vaccination is safe and effective and is a legal requirement for people travelling through infected areas. Avoiding mosquito bites is also recommended to reduce the risk of catching yellow fever or other mosquito-borne diseases.

 

The symptoms of yellow fever
The first symptoms of yellow fever appear three to six days after exposure to the virus. They include:

  • Fever
  • Nausea
  • Vomiting
  • Flushed face
  • Constipation
  • Stomach ache
  • Headache
  • Muscle pain
  • Restlessness and irritability.

 

Mild cases of yellow fever end with the above symptoms. In severe cases, there may be a remission from these symptoms for several hours or days. The fever then returns and the patient develops the classic symptoms of jaundice (yellow eyes and skin) and black, ‘coffee-ground’ vomit. This can be followed by coma and death within days.

 

Requirements and risks of vaccination
Yellow fever vaccine is safe and effective and lasts for 10 years. The vaccine, however, has some strict requirements. It should not be given to people who are:

  • Allergic to eggs or neomycin.
  • Immune-deficient.
  • Pregnant.
  • Under nine months of age – it should only be given to younger infants and pregnant women in unavoidable, high risk circumstances.

Reactions to the vaccine are generally mild and may include fever, headache and muscle ache which occur five to 14 days after immunisation. Serious side effects are rare, but any problems should be immediately referred to a doctor.and mostly in the joint replacement hospitals is available.

 

Reference : http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/Travel_health_…

Arthritis in Hand And Wrist Area of The Body

The hand and wrist have multiple small joints that work together to produce motion. This gives the fine motion needed to thread a needle or tie a shoelace. When the joints are affected by arthritis, activities of daily living can be difficult. Arthritis can occur in multiple areas of the hand and wrist. It can have multiple causes.

It is estimated that one out of every five people living in the United States has at least one joint with signs or symptoms of arthritis. About half of arthritis sufferers are under age 50. Arthritis is the leading cause of disability in the United States. It typically occurs from either disease or trauma. The exact number of people with arthritis in the hand and wrist is not known.

Cause

Cartilage works as nature’s “shock absorber.” It provides a smooth gliding surface for the joint in the  joint replacement hospitals. All arthritic joints lose cartilage. When the cartilage becomes worn or damaged, or is lost due to disease or trauma, the joint no longer has a painless, mobile area of motion.

The body attempts to make up for the lost cartilage. It produces fluid in the joint lining (synovium), which tries to act like a cushion, like water in a waterbed. But it also causes the joint to swell. This restricts motion. The swelling causes stretching of the joint covering (capsule), which causes pain.

Over time, if the arthritis is not treated, the bones that make up the joint can lose their normal shape. This causes more pain and further limits motion.

Disease

When arthritis occurs due to disease, the onset of symptoms is gradual and the cartilage decreases slowly. The two most common forms of arthritis from disease are osteoarthritis and rheumatoid arthritis. Osteoarthritis is much more common and generally affects older people. It appears in a predictable pattern in certain joints. Rheumatoid arthritis has other system-wide symptoms and may be passed from parent to child (genetically).

 

Reference : http://orthoinfo.aaos.org/topic.cfm?topic=A00224

Medical Tourism : – Yellow Fever Vaccination Nagpur

 

Risk of Blood Clot Formation During Joint Replacement Surgery Increases in Certain Patients

Clots more likely to form in patients with cardiovascular disease, smokers and the elderly

Rosemont, IL – When tennis star Serena Williams underwent emergency treatment for a pulmonary embolism earlier this year, the world’s attention was drawn to this often fatal medical condition which, although surprisingly not uncommon, is unfamiliar to most men and women. A common risk factor associated with clot development is surgery; particularly hip and knee replacement surgery.

Pulmonary emboli, or blood clots in the lungs, occur when a clot that forms within veins elsewhere in the body – often in the lower legs or other limbs – breaks free and travels to the lungs, where it can cause serious complications. Pulmonary emboli can occur in patients of any age and common factors associated with an increased risk of clot development include:

  • oral contraceptive use;
  • cardiovascular disease;
  • prior clot formation;
  • clotting disorders;
  • family history of clots; or
  • advanced age.

A new study focusing on the occurrence of clots in knee replacement patients and published in a recent issue of the Journal of Bone and Joint Surgery (JBJS) indicates that despite treatment with blood thinners prior to and immediately following joint replacement surgery, the risk of clot formation is still relatively high in certain patients.

“The rate of knee replacement has increased substantially worldwide, and continued increases are anticipated in the future,” said study author Alma Pedersen, MD, PhD. “The formation of clots, including pulmonary emboli, is a serious complication in patients undergoing knee arthroplasty. Prophylactic measures, such as the use of blood thinners around the time of surgery, are used to reduce the occurrence of clots, but their effectiveness in routine clinical practice following surgery is more uncertain.”

Study Details and Findings
The authors evaluated 37,223 knee replacement patients who had surgery between 1997 and 2007, looking for evidence of post-surgical embolism in the 90-day period following surgery.

The authors found 441 patients (1.2 percent) were hospitalized for blood clots during the 90-day period following knee surgery. An in-depth evaluation of these patient records revealed the following risk factors associated with clot development:

  • advanced age (older than 80 years of age);
  • history of cardiovascular disease;
  • history of previous clot; or
  • increased number of accompanying medical conditions.
  • The study also revealed the number of patients admitted to Healthcare fascicilitator with clots following knee surgery has increased since 1997, which Dr. Pedersen noted is most likely due to advances in diagnosis which have enabled physicians to identify clots before they cause serious problems. The study also notes that individuals who have a knee replacement surgery due to rheumatoid arthritis have a lower risk of clots than those with other conditions. However, in all patients, the risk can be diminished slightly by replacing only one knee at a time, rather than both.

    Although knee surgery is still a generally safe procedure, which enables thousands of men and women each year to regain mobility lost to injury or illness, patients should be aware of the risk of post-surgical clotting and talk with their physician about the possible use of blood thinners and follow-up evaluations that may help to identify clots which may be treated before they cause problems. Although blood thinners are typically prescribed only during hospitalization, the study suggested that physicians consider extending the duration of blood thinner therapy into the weeks following surgery.

    “Despite the use of blood thinners, patients undergoing knee arthroplasty continue to remain susceptible for clot formation for several weeks following surgery,” Dr. Pedersen said. “Future studies should focus on the improvement of prophylaxis following hospital discharge, particularly among elderly patients and those with a history of cardiovascular diseases or previous clot formation.”

     

    Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. None of the authors, or their institution(s), have had any financial relationship, in the thirty-six months prior to submission of this work, with any entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. Also, no author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work.

    More about joint replacement surgery and blood clot formation:
    As the bones are prepared for the new joint in a replacement surgery, tiny microfragments of bone and tissue can become dislodged and enter the bloodstream, “hooking” on vessel walls where they can allow additional debris to accumulate. Eventually, this debris can form a clot large enough to impede the normal flow of blood, sometimes causing discomfort, especially in the lower legs, one of the more common areas of clot formation. Most individuals, however, experience no symptoms of the forming clot. If the clot becomes dislodged from the vessel walls, it can travel through the blood stream, eventually lodging in the lungs. In addition, long periods of immobility prescribed for patients undergoing these surgeries can cause blood flow to slow down, increasing the of clot formation in these patients. If a patient develops swelling, redness or pain in the leg following discharge from the hospital, you should contact your physician.

    More about pulmonary embolism:
    According to data from the American Thoracic Society, pulmonary embolism is a common complication of hospitalization and contributes to 5 to 10 percent of deaths in hospitalized patients. Some studies have estimated that more than 1 million Americans experience pulmonary embolisms each year, with 100,000 to 200,000 of these events being fatal.

     

    Reference : http://www.healthcanal.com/surgery-rehabilitation/19160-Joint-Replacement-Sur…